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Introduction
Epoxides are versatile building blocks widely used in synthesis. 1 The past thirty years have seen the development of many methodologies capable of efficient asymmetric epoxidation of various types of alkene. 2 Dioxiranes, 3 and oxaziridinium salts, first reported by Lusinchi, 4 and generated in situ from the corresponding iminium salts 5 or amines, 6 have proven to be two of the most effective types of organocatalyst for asymmetric oxygen transfer to weakly nucleophilic substrates such as unfunctionalized alkenes. Over the past ten years we have developed a range of enantiopure iminium salts effective as organocatalysts for highly enantioselective asymmetric epoxidation in the presence of Oxone as stoicheiometric oxidant. We have reported that the most reactive and selective iminium salt catalysts discovered to date are based on (S,S)-acetonamine derivative 1 and a biphenyl backbone such as 2, 3 and 4, or a binaphthyl backbone such as 5. For example, iminium species 2a monoperoxysulfate 10 (TPPP) has allowed us to access highly enantioenriched epoxides (up to 99% ee). 12 Using biaryl azepine 6 as a model substrate,
Wallace showed that asymmetric introduction of an alkyl group at C(7) could induce a strong conformational preference for one atropoisomer. 13 Lacour has used derivatization at the 3,3'-positions on the aromatic rings to prevent such interconversion, as in 3a/3b. 14 We have shown that the introduction of an axial substituent at the C(7) position by nucleophilic addition to 2a to create a new chiral centre adjacent to the iminium nitrogen, followed by reoxidation, generates 'second generation' iminium salt catalysts such as 2b, 3b, 4b and 5b, which provide increased enantiocontrol in the epoxidation of alkene substrates. Meyers' bicyclic lactam methodology has been widely used in the stereoselective construction of five-, six-and seven-membered ring nitrogen heterocycles from enantiopure amino alcohols.
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Particularly of interest to us, the methodology has been applied to prepare a range of axially chiral biaryl lactams such as 7. 17 We postulated that structurally related iminium salts such as 8 might impart increased levels of enantioselectivity when used as an asymmetric epoxidation catalyst by imparting additional rigidity and structural elements in the transition state compared to catalysts such as 4.
Results and Discussion
Our initial hypothesis was that the 7,5-fused bicyclic lactam sub-structure 7 could be used to generate amine 9, a suitable precursor to iminium species 8, by reduction of the lactam unit (Scheme 1). However, reduction of compound 7 is known to lead to amino-alcohol 10 using literature procedures. 18 We have previously shown that oxidation of such azepines occurs preferentially at the least substituted adjacent position, ruling out the possibility to use this pathway, because 10 would not be oxidized to 11. 15 We therefore devised an alternative pathway based upon a biaryl coupling of a suitably functionalized oxazolidinone using an adaptation of Fagnou's methodology 19 by Wallace (Scheme 1). 20 Synthesis of the cyclization precursor 12 would be achieved by Suzuki-Miyaura coupling of a suitably functionalized amino-alcohol 14 with 2-acetylphenylboronic acid to give 13, and subsequent hydrolysis of the oxazolidinone protecting group. Cyclocondensation of 12 to form the iminium species 11 would result in concomitant cyclization to the oxazolidine 9 by intramolecular attack of the hydroxyl group. We have previously observed diastereoselective formation of oxazolidines in a related binaphthyl system when generating iminium species bearing an alcohol moiety. 21 Finally, oxidation of 9 under our standard conditions would give iminium salt catalyst 8.
This methodology would allow the use of a wide variety of enantiomerically pure amino-alcohol precursors. Accordingly, alkylation of (R)-phenyl oxazolidinone 15 with 2-iodobenzylbromide afforded N-substituted oxazolidinone 14 in 98% yield. N-Benzyl oxazolidinone 14 was coupled with 2-acetylphenyl boronic acid under conditions used by Levacher. 17a Hydrolysis of the crude oxazolidinone 13 was completed with aqueous sodium hydroxide in dichloromethane; the solvent was removed and tert-butylmethyl ether (TBME) added. The resulting solution of aminoalcohol 12
was treated with aqueous HCl to generate the desired tetracyclic amine 9 via 11 as a single diastereoisomer in 12% yield over the three steps. Finally, the iminium salt 8 was generated by oxidation of the amine using NBS in chloroform in 80% yield.
Scheme 1
We tested iminium salt 8 for its efficacy as an epoxidation catalyst, using 1-phenylcyclohexene as our test substrate under our standard Oxone oxidative conditions. Catalyst 8 gave 100% conversion within thirty minutes, imparting a fair 55% ee for 1-phenylcyclohexene oxide (Scheme 2). 
Scheme 2
While this result established a new sub-structure of iminium salts active for the catalytic asymmetric epoxidation of alkenes, the overall yield of this synthetic route, particularly in the conversion of 14 into 9, coupled with the problematic purification of the unstable oxazolidinone 13 led us to seek an alternative.
We reasoned that a change of aminoalcohol protecting group from oxazolidinone to a much more readily hydrolysed oxaminal might improve the process, and so targeted dimethyloxazolidine 18 (Scheme 3). Reductive amination of 2-iodobenzaldehyde with (R)-phenyl glycinol 16 gave the Nbenzyl amino alcohol 17 in 81% yield. Protection of the aminoalcohol functionality with dimethoxypropane gave the oxazolidine 18 in 96% yield.
Scheme 3
Oxazolidine 18 was coupled with 2-acetylphenylboronic acid under the conditions described above.
Attempted purification using column chromatography on silica gel of the crude coupled product led to the isolation of a mixture of two inseparable compounds. Upon inspection of the 1 H NMR spectrum of the mixture, the two products were identified as the desired Suzuki adduct 19 and the target tetracyclic 6,6,7,5 material 9 as a single diastereoisomer.
Following our conjecture that silica gel had effected a deprotection to expose the aminoalcohol, which then condensed in situ with the pendent ketone generating the desired tetracycle, we subjected the crude reaction mixture from the Suzuki coupling to silica gel in chloroform over 15 h (Scheme 3), so generating tetracycle 9 as a single diastereoisomer in a somewhat improved 40% yield. The absolute configuration of 9 was confirmed by single crystal X-ray analysis. The tetracylic tertiary amine 9 was readily converted into iminium salt 8 in 80% yield. To test the need for the protection/deprotection steps, a Suzuki coupling between unprotected amino-alcohol 17 and 2-acetylphenylboronic acid was attempted.
Anticipating the deactivation of the palladium-phosphine catalyst by the aminoalcohol, we expected to observe poor conversion. To our delight, however, we observed the Suzuki coupling followed by in situ intramolecular cyclization, generating the 6,6,7,5-tetracyclic core 9 as a single diastereoisomer in 40% yield (Scheme 4).
Scheme 4
The phenyl substituted azepinium bromide salt 8 was thus obtained in just four steps in 26% overall yield from (R)-phenyl glycinol 16. A number of aminoalcohols -(S)-alaninol, (S)-valinol, and (R)-& (S)-phenylalaninol -were subjected to the same reaction sequence to prepare a selection of potential catalysts with different substituents at the oxazolidine ring, to give the cyclized products 8 and 28-31, each again generated as single diastereoisomers (Table 1 ; Figure 2 ). Single crystal X-ray structure determination carried out on the (R)-phenyl 9 and (S)-benzyl 27 derivatives ( Figure 3) show the cis-relationship between the methyl groups and the oxazolidine ring phenyl and benzyl substituents derived from the parent aminoalcohols, the pseudo-equatorial placement of these phenyl and benzyl substituents, the axial orientation of the methyl groups, and the chirality of the atropoisomeric biaryl units.
(aR,3R,13bS)-amine 9 (aS,3S,13bR)-amine 27 Figure 3 . Single crystal X-ray structural determination of 9 and 27
The stereoselectivity of the cyclization of the aminoalcohol functionality in the intermediate iminium species 11 may be driven by preferred placement of the smaller methyl substituent in the pseudoaxial orientation (Scheme 5), perhaps through an equilibrium process. 
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Scheme 5
Catalysts 8 and 28-31 were tested for catalytic activity under our standard conditions using oxone as oxidant, and compared to the simple biphenyl azepinium catalyst 2a ( Table 2) . 
Conclusion
To conclude, we have successfully developed a new sub-structure of iminium salt catalyst containing a 6,6,7,5-ring tetracyclic core. The synthesis of these novel iminium salts can be completed within four steps in good yields from the corresponding amino-alcohols. We have postulated that the cyclization occurs through one favoured atropoisomer, giving rise to a favoured diastereoisomer in all the iminium salt catalysts generated, that where the methyl group is pseudo-axial. Catalysts 8, 30
and 31 generally provide enantioselectivities better than or equal to the parent azepinium catalyst 2a.
Experimental Section
General Experimental Detail
All infrared spectra were obtained using; thin films on sodium chloride plates. Tetrahydrofuran and diethyl ether were distilled under a nitrogen atmosphere from the sodium/benzophenone ketyl radical. Acetone was dried over 4Å Linde molecular sieve, and distilled under a nitrogen atmosphere. Enantiomeric excesses were determined by chiral HPLC using a Chiracel OD and OD-H columns with an ultra-violet absorption detector set at 254 nm, by chiral GC using a Chiraldex B-DM column and a flame ionization detector, or by proton nuclear magnetic resonance spectroscopy in the presence of europium (III) tris [3- (heptafluropropylhydroxymethylene)-(+)-camphorate] as the chiral shift reagent.
General procedure A: Reductive amination using 2-iodobenzaldehyde and aminoalcohols
The amino alcohol and 2-iodobenzaldehyde (1.1 equiv.) were dissolved in methanol (10 mL per g of aminoalcohol) and agitated over 5 to 16 h. The mixture was cooled to 0 °C, sodium cyanoborohydride (1.1 equiv.) added, and the mixture stirred at ambient temperature for 16 h.
Saturated aqueous ammonium chloride (1 mL per g of aminoalcohol) was added and the solvent removed under reduced pressure. The residue was dissolved in tert-butyl methyl ether (10 mL per g of aminoalcohol) and the solution washed with saturated brine and dried over magnesium sulphate.
The solvents were removed and the crude oil purified by column chromatography using CH 2 Cl 2 /MeOH (100:0-95:5) as eluent to yield the desired secondary amine.
General procedure B: Suzuki coupling between 2-iodobenzyl aminoalcohols and 2-acetyl phenylboronic acid
The aminoalcohol and 2-acetyl phenylboronic acid (3 equiv.) were dissolved in toluene (10 mL per g of aminoalcohol) and ethanol (1 mL per g of aminoalcohol) and saturated aqueous potassium carbonate (1 mL per g of aminoalcohol) added. The mixture was degassed with nitrogen over 30 min. Pd(PPh 3 ) 4 (10 mol%) was added and the mixture degassed for a further 15 min. The mixture was stirred at reflux under a nitrogen atmosphere with monitoring by HPLC; once complete consumption of the starting material was observed, the mixture was allowed to cool to ambient temperature and filtered through a plug of celite. The organic layer was separated, washed with water, dried over magnesium sulphate, and the solvents were removed under reduced pressure. The residue was dissolved in chloroform (10 mL per g of aminoalcohol and silica gel (0.5 g per g of aminoalcohol) added. The mixture was stirred for 15 hours at room temperature to achieve cyclization. The suspension was filtered through a plug of celite and the solvent removed under reduced pressure. The residue was purified using flash chromatography on silica gel using ethyl acetate:heptane (1-5%) as eluent.
General procedure C: Oxidation of tertiary cyclic amines using N-bromosuccinimide
The amine was dissolved in chloroform (5 mL per g of amine) and the mixture cooled to 0 °C. NBromosuccinimide (2 equiv.) was added. The reaction mixture was removed from the ice bath and stirred for 15-20 min with monitoring by HPLC/TLC. Upon completion, water (10 mL per g of amine) was added, and the organic layer separated and dried over magnesium sulphate. The solvent was removed under reduced pressure to yield the corresponding bromide salt. The residue was dissolved in ethanol (50 mL per g of bromide salt) and a solution of sodium tetraphenylborate (1 equiv.) in the minimum amount of acetonitrile to enable dissolution added. The solvents were removed under reduced pressure and the residue was recrystallized from ethanol to yield the desired tetracyclic imnium tetraphenylborate salts.
General procedure for the formation of racemic epoxides for ee determinations
The alkene was dissolved in dichloromethane (10 mL per g of alkene) and cooled to 0 ºC. m-CPBA (2 equiv.) was added as a solution in dichloromethane (10 mL per g of alkene). The mixture was allowed to attain ambient temperature and stirred until complete consumption of the substrate was observed by TLC. Saturated aqueous NaHCO 3 (20 mL per g of alkene) was added and the layers separated. The organic layer was washed with NaOH (1.0 M, 20 mL per g of alkene), and dried (MgSO 4 ). The solvents were removed under reduced pressure and the product purified by column chromatography, eluting with ethyl acetate/light petroleum (1:99).
General procedure for catalytic asymmetric epoxidation of simple alkenes mediated by iminium salts using Oxone
Oxone (2 equiv.) was added to an ice cooled solution of Na 2 CO 3 , (4 equiv.) in water (8 mL per g of Na 2 CO 3 ), and the resulting foaming solution stirred for 5-10 min. The iminium salt (10 mol%) was added as a solution in acetonitrile (4 mL per g of Na 2 CO 3 used), followed by the alkene substrate, also as a solution in acetonitrile (4 mL per g of Na 2 CO 3 used). The mixture was stirred at 0 °C until the alkene substrate was completely consumed as observed by TLC. The mixture was dissolved in ice-cooled diethyl ether (20 mL per 100 mg substrate), and the same volume of water added. The aqueous phase was washed four times with diethyl ether, and the combined organic layers were washed with saturated brine and dried over magnesium sulphate. Filtration and evaporation of the solvents gave a yellow/brown residue, which was purified by column chromatography, eluting with ethyl acetate/light petroleum (1:99). 7, 59.3, 70.1, 99.0, 127.2, 128.6, 129.2, 129.4, 129.7, 130.0, 137.8, 137.9, 140.0, 158.4 
3-(2'-Iodobenzyl)-4R-phenyloxazolidin-2-one 14
(R)-(-)-4-phenyl
2-(2'-Iodobenzylamino)-2(R)-phenylethanol 17
(R)-Phenylglycinol (1.32 g, 9.60 mmol, 1.1 equiv.) in MeOH (25 mL), 2-iodobenzaldehyde (2.20 g, 9.50 mmol, 1.0 equiv.) and NaBH 3 CN (0.60 g, 9.60 mmol, 1.1 equiv.) were treated using general procedure A to yield the desired product (2.77 g, 7.80 3.81 (1 H, dd, J 4.4, 8.4 Hz), (1 H, m), 7.26-7.40 (7 H, m), 7.80-7.83 (1 H, m); 13 C NMR (100 MHz; CHCl 3 ) δ C 55. 8, 64.0, 67.0, 100.0, 127.5, 127.9, 128.4, 128.8, 129.1, 130.2, 139.8, 140.3, 142 
(aR,3R,13bS)-13b-Methyl-3-phenyl-2,3-dihydro-13bH-dibenz[c,e]oxazolo[3,2-a]azepine 9
First method: from oxazolidinone 14 (4R)-3-(2'-Iodo-benzyl)-4-phenyl-oxazolidin-2-one 14 (0.46 g, 1.21 mmol) was dissolved in toluene (5 mL) and ethanol (7.5 mL). 2-Acetyl phenylboronic acid (0.20 g, 1.21 mmol, 1 equiv.) and saturated aqueous potassium carbonate (5 mL) were added. The mixture was degassed with nitrogen over 30 min. Pd(PPh 3 ) 4 (0.07 g, 0.06 mmol, 5 mol%) was added, and the mixture was degassed with nitrogen for a further 15 min. The mixture was stirred under reflux under a nitrogen atmosphere with monitoring by HPLC. Once complete consumption of the starting material was observed, the mixture was allowed to cool to ambient temperature. The mixture was filtered through a plug of celite, and the solvents were removed under reduced pressure. tert-Butyl methyl ether (10 mL) and water (5 mL) were added to the residue. The organic layer was separated, washed with water (5 mL), and dried over MgSO 4 . The solvents were removed under reduced pressure, and the residue dissolved in ethanol (5 mL) and aqueous NaOH (2M, 5 mL) added. The mixture was heated under reflux for 16 h to remove the protecting goup, then allowed to cool to ambient temperature. The organic solvent was removed under reduced pressure, the residue was dissolved in tert-butyl methyl ether (5 mL), and aqueous HCl (5M, 1 mL) added. The mixture was stirred for 30 min to achieve cyclization, and the organic layer separated, dried over magnesium sulphate and the solvents removed under reduced pressure. The residue was purified using flash chromatography on silica gel using ethyl acetate:heptane (1 -5%) as eluent to give the desired product (0.049 g, 0.15 mmol, 12%).
Second method: from oxazolidine 18
(4R)-3-(2-Iodo-benzyl)-2,2-dimethyl-4-phenyl-oxazolidine 18 (0.69 g, 1.76 mmol) was dissolved in toluene (10 mL) and ethanol (15 mL). 2-Acetyl phenylboronic acid (0.29 g, 1.76 mmol, 1 equiv.) and saturated aqueous potassium carbonate (10 mL) were added. The mixture was degassed with nitrogen over 30 min. Pd(PPh 3 ) 4 (0.10 g, 0.09 mmol, 5 mol%) was added, and the mixture degassed with nitrogen for a further 15 min. The mixture was stirred under reflux under a nitrogen atmosphere for 4 h. The mixture was allowed to cool to ambient temperature, filtered through a plug of celite, and the solvents were removed under reduced pressure. tert-Butyl methyl ether (10 mL) and water (5 mL) were added to the residue. The organic layer was separated, washed with water (5 mL) and dried over MgSO 4 . The solvents were removed under reduced pressure, and the residue dissolved in chloroform (10 mL) and silica gel added. The mixture was stirred at room temperature for 30 min and the suspension filtered through a pad of celite. The solvent was removed under reduced pressure and the residue purified using flash chromatography on silica gel using ethyl acetate:heptane (1-5%)
as eluent to give the desired product (0.23 g, 0.70 mmol, 40%). 6, 52.5, 69.3, 72.8, 97.3, 125.8, 127.6, 127.8, 127.9, 128.00, 128.04, 128.1, 128.5, 128.8, 129.1, 128.2, 135.3, 137.0, 139.1, 140.4, 142 
2S-(2'-Iodobenzylamino)-propan-1-ol 20
(S)-Alaninol (1.3 mL, 16.38 mmol) and 2-iodobenzaldehyde (3.8 g, 16.38 mmol, 1 equiv.) were dissolved in toluene (100 mL) in a round-bottomed flask fitted with a Dean-Stark apparatus. Acetic acid (0.5 mL) was added and the solution heated under reflux for 16 h. The reaction mixture was allowed to reach room temperature and the solvents were removed under reduced pressure. The residue was dissolved in methanol (50 mL), NaBH 3 CN (1.23 g, 19.66 mmol, 1.2 equiv.) and acetic acid (1 mL) were added, and the solution was stirred for 16 h. Saturated aqueous NH 4 Cl (20 mL) was added, and the aqueous layer washed with Et 2 O (3 x 20 mL). The combined organic layers were washed with a saturated solution of aqueous NH 4 Cl (20 mL). The aqueous layers were combined and the pH of the solution was brought to 8-9 using a saturated solution of Na 2 CO 3 . The resulting solution was extracted using dichloromethane (3 x 20 mL) and the combined organic layers were washed with water and brine, dried over MgSO 4 , filtered, and the solvents removed to yield the product (4.0 g, 13.75 mmol, 83%); ν max (film) /cm -1 3324, 2956, 1563, 1435, 1045, 1011, 750, 648. [α] 4, 55.7, 59.5, 62.6, 100.0, 126.7, 128.5, 128.8, 129.2, 129.4, 129.9, 138.4, 139.7, 142. 4, 55.7, 59.5, 62.7, 100.0, 126.7, 128.5, 128.8, 129.1, 129.4, 129.9, 138.4, 139.7, 142. (aS,3S,13bR)-3,13b-Dimethyl-2,3-dihydro-13bH-dibenz [c,e] 5, 52.9, 59.7, 71.7, 97.5, 121.8, 125.9, 127.6, 127.7, 128.1, 128.7, 129.0, 129.3, 134.9, 136.9, 142.4 19.6, 30.2, 30.5, 54.3, 65.8, 70.1, 98.2, 125.2, 127.6, 127.90, 127.91, 128.0, 128.3, 129.1, 135.8, 137.4, 140.5, 142 δ C 30. 6, 39.7, 53.5, 66.2, 69.9, 98.1, 125.4, 126.4, 127.5, 127.8, 128.0, 128.5, 129.0, 129.1, 129.2, 135.0, 137.1, 138.8, 140.1, 142.0 7.20-7.26 (3 H, m), 7.27-7.33 (3 H, m), 7.34-7.41 (3 H, m), 7.42-7.48 (3 H, m), 7.68-7.72 (1 H, m); 13 C NMR (100 MHz; CHCl 3 ) δ C 30. 7, 39.7, 53.6, 66.3, 70.0, 98.2, 125.5, 126.5, 127.6, 127.9, 128.0, 128.6, 129.1, 129.2, 129.3, 135.0, 137.1, 138.9, 140.1, 142 (aS,3S,13bR) e] oxazolo [3,2-a] azepin-5-ium tetraphenylborate salt 28
2S-(2'-Iodobenzylamino)-3-methyl-butan-1-ol 21
Compound 24 (0.21 g, 0.80 mmol) in dichloromethane (2 mL) and N-bromosuccinimide (0.29 g, 1.60 mmol, 2 equiv.) were treated using general procedure C to yield the product (0.20 g, 0.59 mmol, 74%); ν max (film) /cm -1 2965, 1704, 1652, 1558, 1259, 1184, 1102, 1017, 763, 615. [α] 20 D 107.6 ° (c 10.3, CHCl 3 ) ; 1 H NMR (500 MHz; d6-acetone) δ H 1.56 (3 H, s), 1.90 (3 H, d, J 6.8 Hz), 4.48 (1 H, dd, J 2.9, 9.5 Hz), 4.54 (1 H, dd, J 5.3 & 9.5 Hz), m), m), 6.91 (8 H, t, J 7.4 Hz), m), 7.71 (1 H, dt, J 1.5, 7.5 Hz), 7.76 (1 H, dt, J 1.4, 7.5 Hz), m), 7.91 (1 H, dd, J 1.1, 7.6 Hz), 8.10 (1 H, dt, J 1.2, 7.4 Hz), m), 9.67 (1 H, s); 13 C NMR (125 MHz; 23.4, 65.8, 71.5, 100.4, 122.3, 124.6, 126.0 (q, 3 Hz), 129.9, 131.4, 131.5, 131.7, 132.6, 134.6, 136.0, 137.0, 137.9, 139.3, 143.1, 164.4, 164.8, 165.1, 165.5, 165.7 Compound 25 (0.54 g, 1.90 mmol) in dichloromethane (2 mL) and N-bromosuccinimide (0.68 g, 3.80 mmol, 2 equiv.) were treated using general procedure C to yield the product (0.57 g, 1.50 mmol, 81%); ν max (film) /cm -1 3055, 2998, 1639, 1596, 1579, 1559, 1479, 1425, 1377, 1184, 1031, 734. [α] 8, 19.2, 22.2, 31.9, 67.4, 73.6, 100.3, 122.0, 124.3, 125.6, 125.73, 125.75, 125.77, 125.80, 129.7, 131.0, 131.2, 131.4, 132.4, 134.4, 135.6, 136.75, 136.76, 137.6, 139.2, 142.7, 164.1, 164.5, 164.9, 165.3, 166 Compound 9 (0.43 g, 1.32 mmol) in dichloromethane (2 mL) and N-bromosuccinimide (0.47 g, 2.64 mmol, 2 equiv.) were treated using general procedure C to yield the product as a pair of diastereoisomers (0.27 g, 0.66 mmol, 50%); ν max (film) /cm -1 3055, 1709, 1641, 1596, 1579, 1557, 1479, 1426, 1361, 1222, 731, 703 21.4, 71.08, 71.15, 99.8, 121.4, 124.0, 125.1 (q, J 3Hz), 128.6, 128.8, 129.1, 129.9, 130.4, 130.6, 130.7, 130.9, 131.8, 135.6, 136.2 (q, J 1 Hz), 137.4, 142.5, 163.5, 163.9, 164.3, 164.7, 165.7 Compound 26 (0.26 g, 0.80 mmol) in dichloromethane (2 mL) and N-bromosuccinimide (0.29 g, 1.60 mmol, 2 equiv.) were treated using general procedure C to yield the product (0.28 g, 0.66 mmol, 82%); ν max (film) /cm -1 3051, 3013, 1642, 1598, 1581, 1557, 1481, 1426, 1381, 1183, 1031, 1016, 767, 755, 716, 714 3, 40.2, 70.1, 70.5, 100.9, 122.2, 124.4, 125.5, 125.98, 126.00, 126.02, 126.04, 128.9, 130.0, 130.3, 130.9, 131.4, 131.5, 131.7, 132.7, 134.6, 135.3, 136.0, 137.04, 137.05, 138.0, 139.2, 143.0, 134.4, 164.8, 165.2, 165.5, 165 4, 40.3, 70.1, 70.5, 101.0, 122.4, 124.5, 125.5, 126.10, 126.12, 126.15, 126.18, 129.0, 130.1, 130.4, 131.0, 131.5, 131.6, 131.8, 132.8, 134.7, 135.5, 137.13, 137.15, 139.3, 143.1, 164.3, 164.8, 165.8, 165.9 
1-Phenyldihydronaphthalene oxide 24
Isolated as a colourless crystalline solid: ν max (neat)/cm -1 3087, 1601, 1493, 1284, 1176, 1158, 1094, 1072 
Triphenylethylene oxide 8
Isolated as a colourless crystalline solid: ν max (neat)/cm -1 3061, 3031, 2956, 2924, 2857, 1604, 1595, 1498, 1471, 1448, 1262, 1220, 741, 699 
Crystallography
For 9 and 27 diffraction data were collected at 150(2)K and corrections were made for absorption, Lorentz, and polarization factors. Both structures were solved by direct methods and were routine in nature. The absolute structures could not be determined reliably from the diffraction data, so were set from unchanging chiral centres. 
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